Cholesterol and Apoe: A Target for Alzheimer's Disease Therapeutics

E-ISSN： 2212-5299|4|5|553-567

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.4, Iss.5, 2005-10, pp. : 553-567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The APOE Genotype: Modification of Therapeutic Responses in Alzheimer's Disease

Current Pharmaceutical Design, Vol. 21, Iss. 1, 2015-01 ,pp. : 114-120

Bentham Science Publishers

Access to resources Recommend Favorite

Applications of Nanotechnology in Diagnostics and Therapeutics of Alzheimer’s and Parkinson’s Disease

Current Drug Metabolism, Vol. 16, Iss. 8, 2015-10 ,pp. : 705-712

Bentham Science Publishers

Access to resources Recommend Favorite

Designing Multi-Targeted Therapeutics for the Treatment of Alzheimer's Disease

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 17, 2016-07 ,pp. : 1889-1896

Bentham Science Publishers

Access to resources Recommend Favorite

Gelsolin as therapeutic target in Alzheimer's disease

By Carro Eva

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 6, 2010-06 ,pp. : 585-592

Informa Healthcare

Access to resources Recommend Favorite

Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease

By Martiskainen Henna

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 7, 2013-10 ,pp. : 781-794

Informa Healthcare

Access to resources Recommend Favorite